Clinical Trials Browser

Phase 2/3 × Interventional × Insulin Resistance × Clear all

NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Phase 2/3 Completed

Insulin Resistance, Prostatic Neoplasms